RNAZ
Price:
$8.6357
Market Cap:
$7.92M
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; TTX-siLIN28B, an siRNA-based inhibitor of RNA-binding protein LIN28B. Its cancer agnostic programs comprise TTX-RIGA, an RNAbased agonist of the RIG-I-driven immune response in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9based therapy platform for the repair or eliminati...[Read more]
Industry
Biotechnology
IPO Date
2021-07-08
Stock Exchange
NASDAQ
Ticker
RNAZ
According to TransCode Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of TransCode Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), RNAZ's Dividend Yield was at its highest in in the December 2019 quarter at 0%. The Dividend Yield was at its lowest in in the December 2019 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of TransCode Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
The current Dividend Yield of TransCode Therapeutics, Inc. (RNAZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
TransCode Therapeutics, Inc.’s Dividend Yield is less than IN8bio, Inc. (0%), less than Lyra Therapeutics, Inc. (0%), less than Aptevo Therapeutics Inc. (0%), less than Galecto, Inc. (0%), less than Phio Pharmaceuticals Corp. (0%), less than HCW Biologics Inc. (0%), less than Kiora Pharmaceuticals, Inc. (0%), less than Aprea Therapeutics, Inc. (0%), less than Bolt Biotherapeutics, Inc. (0%), less than Acurx Pharmaceuticals, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $8.43M | |
| 0% | $7.99M | |
| 0% | $41.10M | |
| 0% | $30.38M | |
| 0% | $14.53M | |
| 0% | $4.39M | |
| 0% | $7.89M | |
| 0% | $6.47M | |
| 0% | $10.18M | |
| 0% | $5.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TransCode Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TransCode Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is TransCode Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for TransCode Therapeutics, Inc. (RNAZ)?
What is the highest Dividend Yield for TransCode Therapeutics, Inc. (RNAZ)?
What is the 3-year average Dividend Yield for TransCode Therapeutics, Inc. (RNAZ)?
What is the 5-year average Dividend Yield for TransCode Therapeutics, Inc. (RNAZ)?
How does the current Dividend Yield for TransCode Therapeutics, Inc. (RNAZ) compare to its historical average?